Therapy News and Research

RSS

Chemoradiotherapy could be safely avoided in many rectal cancer patients

It’s unclear whether all patients with advanced rectal cancer need chemoradiotherapy, or whether some can forego the treatment and therefore be spared its side effects.

11 May 2018

CRISPR-based treatment can restore retinal function in mice with eye disease

Researchers from Columbia University have developed a new technique for the powerful gene editing tool CRISPR to restore retinal function in mice afflicted by a degenerative retinal disease, retinitis pigmentosa.

11 May 2018

UAB expert highlights need to do more trials in the epidemic center of disease

Frances Lund, Ph.D., the Charles H. McCauley Chair of Microbiology at the University of Alabama at Birmingham, spoke about chronic inflammatory disease and the striking correlation between location and disease incidence at the recent Fourth International Vatican Conference, "Unite to Cure."

11 May 2018

New survey shows 80% of oncologists have discussed medical marijuana use with patients

Data from a new survey show that as many as 80% of oncologists have discussed medical marijuana use with their patients.

11 May 2018

Study explains anti-obesity effects of melatonin

A new study has revealed the mechanism behind the anti-obesity effects of melatonin, a hormone that is released by the pineal gland in the brain overnight.

11 May 2018

Good bacteria is bad news for atherosclerosis

Researchers have discovered that the microbiome heavily influences hardening of the arteries (atherosclerosis), a known risk factor for cardiovascular disease.

11 May 2018

Scientists discover a mechanism through which HIV determines the fate and function of cells

A stem cell is one with infinite possibilities. So, for decades, scientists have puzzled over how the cell chooses to keep being a stem cell and continue dividing, or specialize into a specific cell type, like a heart or brain cell.

11 May 2018

New studies use proteomics to shed light on pathogenic mechanisms

Recent studies in the journal Molecular & Cellular Proteomics have shed light on pathogenic mechanisms of the sexually-transmitted parasite Trichomonas vaginalis and the HIV-associated opportunistic lung fungus Aspergillus.

11 May 2018

New therapeutic strategy exploits acquired vulnerability in drug-resistant cancer

Cancer cells that develop resistance to drugs, pay a price for this, by simultaneously developing a new vulnerability. If this acquired vulnerability can be identified, it may be exploited clinically.

10 May 2018

Early intervention highly effective in reversing lymphedema

A study conducted by researchers at The University of Kansas Cancer Center has found that early, ongoing screening of lymphatic function and immediate patient-administered therapies are highly effective in improving outcomes for women at high risk for breast cancer related lymphedema.

10 May 2018

Art therapy helps veterans cope with trauma and everyday life, study finds

Researchers at The University of Texas at Arlington have found that 98 percent of veterans participating in the University's Artopia program consider that art therapy helped them cope with service-related trauma or disability. An equal percentage reported that art therapy helped them cope with everyday life.

10 May 2018

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

Aravive Biologics, Inc. announced today that the company has demonstrated clinical proof-of-mechanism for AVB-S6-500 in neutralizing GAS6, based on analysis of the single ascending dose portion of the ongoing Phase 1 study.

10 May 2018

CMS approves national reimbursement coverage for CardiAMP Chronic Myocardial Ischemia Trial

BioCardia, Inc., a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the Centers for Medicare and Medicaid Services has approved national reimbursement coverage for the CardiAMP Chronic Myocardial Ischemia Trial.

10 May 2018

Phase 2 study of dexpramipexole in hypereosinophilic syndromes meets its co-primary endpoints

Knopp Biosciences LLC today announced the publication of a report in the journal Blood that a Phase 2 study of dexpramipexole in hypereosinophilic syndromes met its co-primary endpoints.

10 May 2018

Scientific understanding of PSTD points to new treatment and prevention strategies

Recent advances in scientific understanding of how posttraumatic stress disorder develops and persists may lead to more effective treatment and even prevention of this debilitating disorder, according to the May/June special issue of Harvard Review of Psychiatry, published by Wolters Kluwer.

10 May 2018

Early discharge of infants with neonatal abstinence syndrome may prolong their treatment, shows study

Infants who are diagnosed with drug withdrawal after birth who are treated with medication as outpatients at home are treated three times longer than infants treated solely as inpatients, according to a new Vanderbilt study

10 May 2018

ECT is more cost-effective for treating depression than other treatment strategies, shows study

Right now, very few depression patients receive the treatment once known as 'shock therapy', which today uses far milder electrical impulses than decades ago.

10 May 2018

Study discovers genetic variations that increase heart attack risk for statin patients

A Vanderbilt-led research team has discovered genetic variations that increase the risk of heart attack even when patients are receiving a statin drug like Lipitor or Crestor to lower their blood cholesterol.

10 May 2018

Researchers develop artificial intelligence method to help cancer patients worldwide

Before performing radiation therapy, radiation oncologists first carefully review medical images of a patient to identify the gross tumor volume -- the observable portion of the disease. They then design patient-specific clinical target volumes that include surrounding tissues, since these regions can hide cancerous cells and provide pathways for metastasis.

10 May 2018

New case study shows CAR T therapy as viable option for AML patients

Chimeric Antigen Receptor T-cell therapy, also known as CAR T therapy, was named the biggest research breakthrough of 2017 by the American Society of Clinical Oncology. The personal gene therapy utilizes a patient's own immune cells to fight cancer.

9 May 2018

Therapy News and Research

Chemoradiotherapy could be safely avoided in many rectal cancer patients

CRISPR-based treatment can restore retinal function in mice with eye disease

UAB expert highlights need to do more trials in the epidemic center of disease

New survey shows 80% of oncologists have discussed medical marijuana use with patients

Study explains anti-obesity effects of melatonin

Good bacteria is bad news for atherosclerosis

Scientists discover a mechanism through which HIV determines the fate and function of cells

New studies use proteomics to shed light on pathogenic mechanisms

New therapeutic strategy exploits acquired vulnerability in drug-resistant cancer

Early intervention highly effective in reversing lymphedema

Art therapy helps veterans cope with trauma and everyday life, study finds

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

CMS approves national reimbursement coverage for CardiAMP Chronic Myocardial Ischemia Trial

Phase 2 study of dexpramipexole in hypereosinophilic syndromes meets its co-primary endpoints

Scientific understanding of PSTD points to new treatment and prevention strategies

Early discharge of infants with neonatal abstinence syndrome may prolong their treatment, shows study

ECT is more cost-effective for treating depression than other treatment strategies, shows study

Study discovers genetic variations that increase heart attack risk for statin patients

Researchers develop artificial intelligence method to help cancer patients worldwide

New case study shows CAR T therapy as viable option for AML patients

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News